Variability of commercial cranberry dietary supplements for the prevention of uropathogenic bacterial adhesion

1Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

OBJECTIVES: Cranberry has been known to reduce the number of urinary tract infections. Research suggests that the proanthocyanidins (PACs) in cranberry fruit actively prevent bacterial adhesion to the bladder wall, thereby preventing infection. We sought to measure the levels of PACs in commercially available cranberry products. MATERIALS AND METHODS: Seven cranberry products were tested for bacterial anti-adhesion activity using a hemagglutination assay specific for P-fimbriated Escherichia coli. PACs were isolated using the gravimetric technique (C-18 followed by Sephadex LH-20 solid phase chromatography) to determine levels in each product and tested for anti-adhesion activity on an equal weight basis (starting concentration of 5 mg/mL). RESULTS: Whole products anti-adhesion activity ranged from 0.47 to 60 mg/mL. PAC levels ranged from 0.56 to 175 mg/g. Whole product anti-adhesion activity for four of the products was not able to be detected. See Table 1. CONCLUSION: There is a large amount of variability in the amount and bioactivity of PACs in commercially available cranberry product. In addition, there were several products that contained virtually no active component of cranberry. (Table Presented).

Cite

CITATION STYLE

APA

Chughtai, B., Thomas, D., & Howell, A. (2016, July 1). Variability of commercial cranberry dietary supplements for the prevention of uropathogenic bacterial adhesion. American Journal of Obstetrics and Gynecology. Mosby Inc. https://doi.org/10.1016/j.ajog.2016.03.046

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free